Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News and Analysis
  • Published:

2007: Spotlight on drug safety

Abstract

What have been some of the past year's key events and trends for the biopharma industry?

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. NEJM 356, 2457–2471 (2007).

  2. Nature Rev. Drug Discov . 6, 505–506 (2007).

  3. Nature Rev. Drug Discov . 6, 855–856 (2007).

  4. Nature Rev. Drug Discov . 6, 769–771 (2007).

  5. FDA subcommittee report [online], (2007).

  6. Nature Rev. Drug Discov . 6, 688–689 (2007).

  7. Nature Rev. Drug Discov . 6, 437–442 (2007).

  8. Nature Rev. Drug Discov . 6, 590–591 (2007).

  9. Nature Rev. Drug Discov . 6, 770–771 (2007).

  10. Nature Rev. Drug Discov . 6, 945 (2007).

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hughes, B. 2007: Spotlight on drug safety. Nat Rev Drug Discov 7, 5–7 (2008). https://doi.org/10.1038/nrd2503

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd2503

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing